Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending March 10, 2023

Drug Industry TRx: +7.8% w/w; -0.5% y/y

Vascepa
TRx 61,981; +0.9% (+576) w/w; -12.7% y/y
NRx 29,579; +3.3% (+947) w/w; -11.0% y/y
Ref 32,402; -1.1% (-370) w/w; -14.2% y/y

Fake Vascepa
TRx 46,168; +0.2% (+94) w/w; As % of total V: 42.7%
NRx 22,880; -0.1% (-17) w/w; As % of total V: 43.6%
Ref 23,288; +2.8% (+111) w/w; As % of total V: 41.8%

Fake Vascepa by Manufacturer
Hikma TRx 17,291; Gen share 37.5% Total V share 16.0%
Reddy TRx 18,567; Gen share 40.2%; Total V share 17.2%
Apotex TRx 8,724; Gen share 18.9%; Total V share 8.1%
Teva TRx 746; Gen share 1.6%; Total V share 0.7%
Northstar TRx 840; Gen share 1.8%; Total V share 0.8%

Vascepa + Fake Vascepa
TRx 108,149; +0.6% (+670) w/w; +6.4% y/y
NRx 52,459; +1.8% (+929) w/w; +3.3% y/y
Ref 55,691; -0.5% (-259) w/w; +9.6% y/y

Lovaza (Fake & Brand)
TRx 67,125; +1.6% (+1,069) w/w; +5.7% y/y
NRx 33,937; +2.7% (+900) w/w; +2.1% y/y
Ref 33,188; +0.5% (+169) w/w; +9.7% y/y